+关注
ChewWeiKiat
暂无个人介绍
IP属地：未知
4
关注
1
粉丝
0
主题
0
勋章
主贴
热门
ChewWeiKiat
2021-12-26
Good good good good yes
3 Best Buffett Stocks to Buy for the Long Haul
ChewWeiKiat
2021-12-26
Good
2 Top Tech Stocks to Buy During a Recession
ChewWeiKiat
2021-12-26
Good
3 Bargain Stocks That Cathie Wood Loves
ChewWeiKiat
2021-12-22
Good
抱歉，原内容已删除
ChewWeiKiat
2021-12-10
The market is unstable now[微笑] [呆住]
抱歉，原内容已删除
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3580859173247698","uuid":"3580859173247698","gmtCreate":1617773996559,"gmtModify":1639142340436,"name":"ChewWeiKiat","pinyin":"chewweikiat","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/131da1c18d7a77a7044724a63dbc30f8","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":4,"tweetSize":5,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.08.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.02.06","exceedPercentage":"60.60%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.01.30","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":698444827,"gmtCreate":1640514226693,"gmtModify":1640514226804,"author":{"id":"3580859173247698","authorId":"3580859173247698","name":"ChewWeiKiat","avatar":"https://static.tigerbbs.com/131da1c18d7a77a7044724a63dbc30f8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580859173247698","authorIdStr":"3580859173247698"},"themes":[],"htmlText":"Good good good good yes","listText":"Good good good good yes","text":"Good good good good yes","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698444827","repostId":"2193917872","repostType":4,"repost":{"id":"2193917872","kind":"highlight","pubTimestamp":1640398248,"share":"https://www.laohu8.com/m/news/2193917872?lang=&edition=full","pubTime":"2021-12-25 10:10","market":"us","language":"en","title":"3 Best Buffett Stocks to Buy for the Long Haul","url":"https://stock-news.laohu8.com/highlight/detail?id=2193917872","media":"Motley Fool","summary":"Each of these three big pharma stocks are featured in Berkshire Hathaway's massive portfolio.","content":"<p>Since Warren Buffett took full control of <b>Berkshire Hathaway</b> in 1965, it became a diversified holding company with investments in publicly traded companies totaling nearly $345 billion at the time of writing.</p>\n<p>The Oracle of Omaha's reputation of buying the highest quality businesses means that many individual investors could also benefit from adding these stocks to their portfolios. Here are three healthcare stocks that Buffett owns, which you may also want to consider buying and holding for the long run.</p>\n<h2>1. Johnson & Johnson</h2>\n<p>The first pharma stock within Berkshire's portfolio to contemplate purchasing is <b>Johnson & Johnson</b> (NYSE:JNJ). While the stock is one of Buffett's smallest holdings, valued at just under $55 million, this doesn't take away from its 59 consecutive years of dividend increases that make the stock a Dividend King.</p>\n<p>J&J will be spinning off its slower-growing and less profitable consumer health segment in the next 18 to 24 months, which should allow the company to focus on its faster-growing, more profitable pharmaceutical segment.</p>\n<p>J&J has a strong existing drug portfolio, which should be able to make up for the upcoming 2025 to 2026 patent expirations for its top-selling drug known, Stelara. Year to date, the immunology drug made up just 9.9% of J&J's $69 billion in net sales.</p>\n<p>These drugs include the immunology blockbuster Tremfya, which received its first of three U.S. Food and Drug Administration (FDA) approvals to date in July 2017. Another drug that was recently approved by the FDA was the oncology blockbuster called Darzalex, which received its first of nine FDA approvals to date in November 2015. These two drugs have grown their year-to-date revenue at high-40% clips year over year and should remain under patent most of this decade.</p>\n<p>J&J's enviable existing drug portfolio and its nearly four dozen indications in late-stage clinical trials explain why analysts anticipate that the stock will deliver 8% annual non-GAAP (adjusted) earnings per share (EPS) growth over the next five years.</p>\n<p>Income investors can scoop up J&J's 2.5% dividend yield at a forward P/E ratio of just 16.2 times, which makes the steady healthcare stock a great buy for the long term.</p>\n<h2>2. Bristol Myers Squibb</h2>\n<p>Another Buffett stock that could be a great fit in your portfolio is <b>Bristol Myers Squibb</b> (NYSE:BMY). Berkshire's Bristol Myers Squibb stake totals nearly $1.4 billion, making it one of the largest healthcare holdings in Berkshire's portfolio.</p>\n<p>Bristol Myers Squibb's oncology blockbusters Revlimid and Opdivo and the anticoagulant blockbuster co-owned with <b>Pfizer</b> (NYSE:PFE) named Eliquis each face patent expirations later this decade. While looming patent expirations on three drugs that account for approximately two-thirds of your company's total revenue sounds frightening, this is nothing new; it's just the nature of Bristol Myers Squibb's industry.</p>\n<p>What matters most is that a company is proactive in developing and acquiring its next generation of blockbuster drugs to absorb key patent expirations. With more than 50 compounds in over 40 different disease areas currently in development at Bristol Myers Squibb, this is exactly what the company has been doing for years now.</p>\n<p>As a result, analysts are projecting that Bristol Myers Squibb will be able to generate 6% annual earnings growth through the next five years.</p>\n<p>Yield-hungry investors can buy Bristol Myers Squibb's market-crushing 3.5% yield at a ridiculously cheap forward P/E ratio of 7.9, which is what makes the stock a buy for those looking to hedge against inflation.</p>\n<h2>3. AbbVie</h2>\n<p>Finally, a Buffett stock that'd also be a good fit for income investors is <b>AbbVie</b> (NYSE:ABBV). Berkshire currently holds about $1.9 billion worth of AbbVie stock.</p>\n<p>It's well known at this point that the biopharmaceutical's top-selling drug in the world, Humira, will be facing intense biosimilar competition in the U.S. beginning in 2023. Even though the immunology drug's U.S. sales made up 31% of AbbVie's $41.24 billion total year-to-date sales, the company's pipeline should be able to stabilize and grow its net revenue beyond 2023.</p>\n<p>AbbVie has 54 compounds in various stages of clinical trials, which is why analysts are forecasting that the stock will grow its adjusted EPS 4.5% annually in the next five years.</p>\n<p>AbbVie's massive 4.4% dividend yield can be picked up at a forward P/E ratio of only 9.3. This is an attractive valuation for a stock with the ability to fight off inflation with healthy dividend hikes.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Best Buffett Stocks to Buy for the Long Haul</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Best Buffett Stocks to Buy for the Long Haul\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-25 10:10 GMT+8 <a href=https://www.fool.com/investing/2021/12/24/3-best-buffett-stocks-to-buy-for-the-long-haul/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Since Warren Buffett took full control of Berkshire Hathaway in 1965, it became a diversified holding company with investments in publicly traded companies totaling nearly $345 billion at the time of ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/24/3-best-buffett-stocks-to-buy-for-the-long-haul/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","BMY":"施贵宝","ABBV":"艾伯维公司"},"source_url":"https://www.fool.com/investing/2021/12/24/3-best-buffett-stocks-to-buy-for-the-long-haul/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193917872","content_text":"Since Warren Buffett took full control of Berkshire Hathaway in 1965, it became a diversified holding company with investments in publicly traded companies totaling nearly $345 billion at the time of writing.\nThe Oracle of Omaha's reputation of buying the highest quality businesses means that many individual investors could also benefit from adding these stocks to their portfolios. Here are three healthcare stocks that Buffett owns, which you may also want to consider buying and holding for the long run.\n1. Johnson & Johnson\nThe first pharma stock within Berkshire's portfolio to contemplate purchasing is Johnson & Johnson (NYSE:JNJ). While the stock is one of Buffett's smallest holdings, valued at just under $55 million, this doesn't take away from its 59 consecutive years of dividend increases that make the stock a Dividend King.\nJ&J will be spinning off its slower-growing and less profitable consumer health segment in the next 18 to 24 months, which should allow the company to focus on its faster-growing, more profitable pharmaceutical segment.\nJ&J has a strong existing drug portfolio, which should be able to make up for the upcoming 2025 to 2026 patent expirations for its top-selling drug known, Stelara. Year to date, the immunology drug made up just 9.9% of J&J's $69 billion in net sales.\nThese drugs include the immunology blockbuster Tremfya, which received its first of three U.S. Food and Drug Administration (FDA) approvals to date in July 2017. Another drug that was recently approved by the FDA was the oncology blockbuster called Darzalex, which received its first of nine FDA approvals to date in November 2015. These two drugs have grown their year-to-date revenue at high-40% clips year over year and should remain under patent most of this decade.\nJ&J's enviable existing drug portfolio and its nearly four dozen indications in late-stage clinical trials explain why analysts anticipate that the stock will deliver 8% annual non-GAAP (adjusted) earnings per share (EPS) growth over the next five years.\nIncome investors can scoop up J&J's 2.5% dividend yield at a forward P/E ratio of just 16.2 times, which makes the steady healthcare stock a great buy for the long term.\n2. Bristol Myers Squibb\nAnother Buffett stock that could be a great fit in your portfolio is Bristol Myers Squibb (NYSE:BMY). Berkshire's Bristol Myers Squibb stake totals nearly $1.4 billion, making it one of the largest healthcare holdings in Berkshire's portfolio.\nBristol Myers Squibb's oncology blockbusters Revlimid and Opdivo and the anticoagulant blockbuster co-owned with Pfizer (NYSE:PFE) named Eliquis each face patent expirations later this decade. While looming patent expirations on three drugs that account for approximately two-thirds of your company's total revenue sounds frightening, this is nothing new; it's just the nature of Bristol Myers Squibb's industry.\nWhat matters most is that a company is proactive in developing and acquiring its next generation of blockbuster drugs to absorb key patent expirations. With more than 50 compounds in over 40 different disease areas currently in development at Bristol Myers Squibb, this is exactly what the company has been doing for years now.\nAs a result, analysts are projecting that Bristol Myers Squibb will be able to generate 6% annual earnings growth through the next five years.\nYield-hungry investors can buy Bristol Myers Squibb's market-crushing 3.5% yield at a ridiculously cheap forward P/E ratio of 7.9, which is what makes the stock a buy for those looking to hedge against inflation.\n3. AbbVie\nFinally, a Buffett stock that'd also be a good fit for income investors is AbbVie (NYSE:ABBV). Berkshire currently holds about $1.9 billion worth of AbbVie stock.\nIt's well known at this point that the biopharmaceutical's top-selling drug in the world, Humira, will be facing intense biosimilar competition in the U.S. beginning in 2023. Even though the immunology drug's U.S. sales made up 31% of AbbVie's $41.24 billion total year-to-date sales, the company's pipeline should be able to stabilize and grow its net revenue beyond 2023.\nAbbVie has 54 compounds in various stages of clinical trials, which is why analysts are forecasting that the stock will grow its adjusted EPS 4.5% annually in the next five years.\nAbbVie's massive 4.4% dividend yield can be picked up at a forward P/E ratio of only 9.3. This is an attractive valuation for a stock with the ability to fight off inflation with healthy dividend hikes.","news_type":1},"isVote":1,"tweetType":1,"viewCount":822,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698444160,"gmtCreate":1640514148243,"gmtModify":1640514148243,"author":{"id":"3580859173247698","authorId":"3580859173247698","name":"ChewWeiKiat","avatar":"https://static.tigerbbs.com/131da1c18d7a77a7044724a63dbc30f8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580859173247698","authorIdStr":"3580859173247698"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/698444160","repostId":"2193781141","repostType":4,"repost":{"id":"2193781141","kind":"highlight","pubTimestamp":1640485676,"share":"https://www.laohu8.com/m/news/2193781141?lang=&edition=full","pubTime":"2021-12-26 10:27","market":"us","language":"en","title":"2 Top Tech Stocks to Buy During a Recession","url":"https://stock-news.laohu8.com/highlight/detail?id=2193781141","media":"Motley Fool","summary":"Market crashes are inevitable, but they're the perfect time to buy great businesses at a discount.","content":"<p>We're days away from the end of 2021, and the <b>S&P 500</b> has put on a master class in outperforming expectations. Even with its pullback in recent days, the broad market index has gained nearly 30% this year, more than double its long-term historical average.</p>\n<p>Yet that just means we're another day closer to the inevitable market correction. Just as night follows day, a stock market crash is inevitable because market declines are a natural part of the normal business and investment cycle. No <a href=\"https://laohu8.com/S/AONE.U\">one</a> can forecast exactly when it will strike, but smart investors realize it's best to prepare for the eventuality.</p>\n<p>For as long as people have been investing, stretching even as far back to the Dutch tulip mania in the 1600s, busts have followed booms. And what a boom we've enjoyed! Since the bottom of the Great Recession, the S&P 500 has quadrupled in value.</p>\n<p>2020's pandemic-driven 34% drop in the stock indexes within the span of just a few weeks was the worst on record. But savvy investors don't have to worry. These events are not a problem when you're invested in the right companies. Being prepared for the worst and hoping for the best means when the next stock market crash or correction occurs, you'll want to have your money invested in stocks that will help lead the way forward. Here are two tech stocks you'll want to buy.</p>\n<h2>1. Apple</h2>\n<p>The burden that inflation is imposing on consumers also poses a threat to some of the biggest, best-run businesses, like <b>Apple</b> (NASDAQ:AAPL), which is currently benefiting from the smartphone upgrade cycle and the rollout of 5G network infrastructure. Any attempt by the Federal Reserve to raise interest rates to contain runaway inflation could cause an economic slowdown by making money more expensive to borrow. Stock valuations would also turn lower.</p>\n<p>That's not necessarily bad news for investors who might find Apple's $2.8 trillion valuation a bit rich to buy into at the moment. The stock trades at 30 times trailing earnings, or about double its typical multiple. A correction would bring Apple back into the realm of the attainable, even as its business continues jogging forward.</p>\n<p>Sales of the iPhone 13 are outpacing those of the iPhone 12 at the same time, but Apple reportedly warned suppliers that demand is waning as the calendar year progresses. It's not necessarily for a lack of consumer desire, but rather the global supply chain constraints that have made it difficult to find the product. Apple previously cut its iPhone production target by 10 million units from its original goal of 90 million.</p>\n<p>Analysts think many consumers may choose to forgo the iPhone 13 and wait for the next upgrade. Coupled with a market crash, that could put Apple stock at a very attractive entry point with pent-up demand for the next iteration of the iPhone.</p>\n<h2>2. Amazon</h2>\n<p>Few companies are as essential to the working of the U.S. economy as <b>Amazon</b> (NASDAQ:AMZN). It will account for 41.4% of all online spending in the U.S. this year, according to eMarketer estimates. At the same time, Amazon Web Services (AWS), its cloud infrastructure business, is on track to generate over $60 billion in annual revenue in 2021 based on its year-to-date performance. The company is responsible for thousands of web-based businesses and the federal government's ability to remain online, making Amazon crucial to a well-functioning economy.</p>\n<p>That won't change if the stock market collapses. Its share of U.S. retail e-commerce sales will be more than 50% larger than the shares of the next nine e-commerce companies combined. Amazon's piece of the online market is nearly six times more than <b>Walmart</b>'s second-place share at just 7.2%, and 10 times greater than third-place <b><a href=\"https://laohu8.com/S/EBAY\">eBay</a></b>. E-commerce data tracker Edge by Ascential expects Amazon will see $26.7 billion just in online grocery sales five from now years, or nearly double its current amount.</p>\n<p>Amid rising prices and supply chain woes, Amazon has become a lifeline for many, and that will continue long after any financial restructuring. The stock gained 76% during the first year of the pandemic and took a breather during the reopening of the economy. Amazon shares have been relatively flat all year long. A correction would allow investors to buy a tech stock at a more reasonable valuation even as its crucial role only gets reinforced.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Top Tech Stocks to Buy During a Recession</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Top Tech Stocks to Buy During a Recession\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-26 10:27 GMT+8 <a href=https://www.fool.com/investing/2021/12/24/2-top-tech-stocks-to-buy-during-a-recession/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>We're days away from the end of 2021, and the S&P 500 has put on a master class in outperforming expectations. Even with its pullback in recent days, the broad market index has gained nearly 30% ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/24/2-top-tech-stocks-to-buy-during-a-recession/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊","BK4515":"5G概念","BK4554":"元宇宙及AR概念","BK4532":"文艺复兴科技持仓","BK4553":"喜马拉雅资本持仓","BK4507":"流媒体概念","BK4534":"瑞士信贷持仓","AAPL":"苹果","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4566":"资本集团","BK4535":"淡马锡持仓","BK4524":"宅经济概念","BK4527":"明星科技股","BK4538":"云计算","BK4559":"巴菲特持仓","BK4501":"段永平概念","BK4550":"红杉资本持仓","BK4503":"景林资产持仓","BK4122":"互联网与直销零售","BK4551":"寇图资本持仓","BK4561":"索罗斯持仓","BK4505":"高瓴资本持仓","BK4548":"巴美列捷福持仓","BK4170":"电脑硬件、储存设备及电脑周边"},"source_url":"https://www.fool.com/investing/2021/12/24/2-top-tech-stocks-to-buy-during-a-recession/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193781141","content_text":"We're days away from the end of 2021, and the S&P 500 has put on a master class in outperforming expectations. Even with its pullback in recent days, the broad market index has gained nearly 30% this year, more than double its long-term historical average.\nYet that just means we're another day closer to the inevitable market correction. Just as night follows day, a stock market crash is inevitable because market declines are a natural part of the normal business and investment cycle. No one can forecast exactly when it will strike, but smart investors realize it's best to prepare for the eventuality.\nFor as long as people have been investing, stretching even as far back to the Dutch tulip mania in the 1600s, busts have followed booms. And what a boom we've enjoyed! Since the bottom of the Great Recession, the S&P 500 has quadrupled in value.\n2020's pandemic-driven 34% drop in the stock indexes within the span of just a few weeks was the worst on record. But savvy investors don't have to worry. These events are not a problem when you're invested in the right companies. Being prepared for the worst and hoping for the best means when the next stock market crash or correction occurs, you'll want to have your money invested in stocks that will help lead the way forward. Here are two tech stocks you'll want to buy.\n1. Apple\nThe burden that inflation is imposing on consumers also poses a threat to some of the biggest, best-run businesses, like Apple (NASDAQ:AAPL), which is currently benefiting from the smartphone upgrade cycle and the rollout of 5G network infrastructure. Any attempt by the Federal Reserve to raise interest rates to contain runaway inflation could cause an economic slowdown by making money more expensive to borrow. Stock valuations would also turn lower.\nThat's not necessarily bad news for investors who might find Apple's $2.8 trillion valuation a bit rich to buy into at the moment. The stock trades at 30 times trailing earnings, or about double its typical multiple. A correction would bring Apple back into the realm of the attainable, even as its business continues jogging forward.\nSales of the iPhone 13 are outpacing those of the iPhone 12 at the same time, but Apple reportedly warned suppliers that demand is waning as the calendar year progresses. It's not necessarily for a lack of consumer desire, but rather the global supply chain constraints that have made it difficult to find the product. Apple previously cut its iPhone production target by 10 million units from its original goal of 90 million.\nAnalysts think many consumers may choose to forgo the iPhone 13 and wait for the next upgrade. Coupled with a market crash, that could put Apple stock at a very attractive entry point with pent-up demand for the next iteration of the iPhone.\n2. Amazon\nFew companies are as essential to the working of the U.S. economy as Amazon (NASDAQ:AMZN). It will account for 41.4% of all online spending in the U.S. this year, according to eMarketer estimates. At the same time, Amazon Web Services (AWS), its cloud infrastructure business, is on track to generate over $60 billion in annual revenue in 2021 based on its year-to-date performance. The company is responsible for thousands of web-based businesses and the federal government's ability to remain online, making Amazon crucial to a well-functioning economy.\nThat won't change if the stock market collapses. Its share of U.S. retail e-commerce sales will be more than 50% larger than the shares of the next nine e-commerce companies combined. Amazon's piece of the online market is nearly six times more than Walmart's second-place share at just 7.2%, and 10 times greater than third-place eBay. E-commerce data tracker Edge by Ascential expects Amazon will see $26.7 billion just in online grocery sales five from now years, or nearly double its current amount.\nAmid rising prices and supply chain woes, Amazon has become a lifeline for many, and that will continue long after any financial restructuring. The stock gained 76% during the first year of the pandemic and took a breather during the reopening of the economy. Amazon shares have been relatively flat all year long. A correction would allow investors to buy a tech stock at a more reasonable valuation even as its crucial role only gets reinforced.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1012,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698444916,"gmtCreate":1640514110389,"gmtModify":1640514110440,"author":{"id":"3580859173247698","authorId":"3580859173247698","name":"ChewWeiKiat","avatar":"https://static.tigerbbs.com/131da1c18d7a77a7044724a63dbc30f8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580859173247698","authorIdStr":"3580859173247698"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/698444916","repostId":"2193178197","repostType":4,"repost":{"id":"2193178197","kind":"highlight","pubTimestamp":1640485804,"share":"https://www.laohu8.com/m/news/2193178197?lang=&edition=full","pubTime":"2021-12-26 10:30","market":"us","language":"en","title":"3 Bargain Stocks That Cathie Wood Loves","url":"https://stock-news.laohu8.com/highlight/detail?id=2193178197","media":"Motley Fool","summary":"Is now the best time to buy these three Wood picks?","content":"<p>After an astounding 2020, the chief investment officer of ARK Invest and stock picker extraordinaire Cathie Wood has had a rough 2021. The <b><a href=\"https://laohu8.com/S/ARKK\">ARK Innovation ETF</a></b> (NYSEMKT:ARKK) is down 38% off its all-time high and down 22% year to date.</p>\n<p>ARK and Wood invest in lots of high-growth tech stocks that have been battered this year, which is what's causing the fund's poor performance. <b>Coinbase Global</b> (NASDAQ:COIN), <b>Shopify</b> (NYSE:SHOP), and <b><a href=\"https://laohu8.com/S/PATH\">UiPath</a></b> (NYSE:PATH) are some of Cathie Wood's favorites, and all are between 20% and 50% off their all-time highs. However, the fact that millions of dollars of their stock are sitting in Wood's ETFs should be indicative of their long-term potential. These companies are trading at bargain prices today, so you might want to consider putting them on your watchlist.</p>\n<h2>Coinbase: A way to invest in crypto</h2>\n<p>Coinbase is ARK Invest's third-largest holding, clocking in at a market value of $1.25 billion. Shares of the world's largest cryptocurrency exchange have sunk like a stone recently, falling 32% off its all-time highs. However, this isn't fully indicative of business performance.</p>\n<p>With over $255 billion in assets across 100 different countries and 72 million users, Coinbase has become a cornerstone of the crypto economy as <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the leading, most trusted cryptocurrency exchanges. The company takes a cut of every purchase of crypto on the platform, so the rise in popularity of cryptocurrency has resulted in impressive revenue success. The company's revenue increased by over 330% year over year in Q3. With this, the company has also achieved impressive profitability: Coinbase brought almost one-third of its revenue to the bottom line.</p>\n<p>While its reliance on cryptocurrencies like <b>Bitcoin</b> (CRYPTO:BTC) has led to amazing growth recently, it's really a double-edged sword. The company makes money only on purchases of crypto, so in large-scale crypto sell-offs, the company is left stranded. This leaves Coinbase largely vulnerable to the winds of the crypto markets.</p>\n<p>With the recent sell-off of crypto and Bitcoin, Coinbase has followed suit -- falling to a valuation of just 22 times earnings. Whether this is justified or not, Coinbase will likely mimic the crypto market, and its success largely depends on the widespread adoption of crypto. Therefore, if you think that cryptocurrencies will skyrocket over the next decade, Coinbase could be a smart investment.</p>\n<h2>UiPath: An AI pureplay</h2>\n<p>While not as large as Coinbase, ARK ETFs hold over $1 billion of UiPath stock -- making it the sixth-largest holding across all of Wood's funds. UiPath is disrupting the way companies operate and handle tedious, repetitive tasks by normalizing the use of artificial intelligence and bots. The company has the vision to deliver a fully automated enterprise so that workers can optimize their efficiency, and the way the company is doing this has attracted companies like <b>AutoDesk</b> (NASDAQ:ADSK) and NASA.</p>\n<p>While UiPath's product sounds like a pie-in-the-sky dream, the company is more than real. It has over 9,600 customers and $818 million in annual recurring revenue (ARR). With such dominance, UiPath has been named a market leader in the robotic process automation (RPA) market in <b>Gartner</b>'s Magic Quadrant. As the leader, it has gained the trust and confidence of companies that might be wary of bringing automation and robots into the workplace.</p>\n<p>UiPath has lots of potential to grow. The company sees a $30 billion addressable opportunity by 2024, which would be immense growth from its current $818 million in ARR. UiPath might get some pushback along the way from those wary of integrating robots into the workplace, but its robots can provide efficiency improvements. The company has saved its customers millions of hours and dollars without putting workers' jobs on the line. UiPath is meant to work alongside human employees, and it has been successful in doing so.</p>\n<p>Shares have fallen drastically since it came public earlier this year, and that has provided a valuation that an appealing valuation public at 60 times sales, but it now trades at 22 times sales. Cathie Wood has taken the opportunity to buy more shares this December, and you might want to consider doing the same.</p>\n<h2>Shopify: The rising e-commerce pick</h2>\n<p>Shopify is farther down at the 11th-largest ARK position, but still represents $950 million worth of shares -- and for good reason. The company has doubled its gross merchandise volume (GMV) over the past 16 months, reaching $400 billion in cumulative GMV on its merchants' platforms in Q3. This has been because of the company's relentless focus on its customers' growth and success. This is unrivaled by competitors like <b>Amazon</b> (NASDAQ:AMZN), which have often stifled SMBs by noticing their success and then offering and promoting a self-developed product that competes with them directly.</p>\n<p>The company recently announced a new feature that would make international sales easier for merchants. Shopify Markets would allow companies to streamline global expansion -- something many Shopify users might never have thought possible. The company also has plans to roll out additional features over the next few years, with one of my personal favorites being Shopify Fulfillment. With this, users could access the fulfillment network that Shopify is building out and let the company pack and ship orders for them.</p>\n<p>This focus on customer success is truly unique, which is why the company demands a very high premium. The company trades at roughly 40 times sales, which is the highest valuation out of these three stocks. However, I also believe that Shopify is the highest-quality stock on this list. While all three of these stocks are appealing, Shopify has proven itself the most, and the company's expansion efforts beyond SMB look very promising. While there is more risk that share prices could continue dropping, I think it is worth paying up for high-quality companies, and Shopify fits that bill. Given the number of shares that Cathie Wood owns, I think she is in agreement.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Bargain Stocks That Cathie Wood Loves</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Bargain Stocks That Cathie Wood Loves\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-26 10:30 GMT+8 <a href=https://www.fool.com/investing/2021/12/24/3-bargain-stocks-that-cathie-wood-loves/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After an astounding 2020, the chief investment officer of ARK Invest and stock picker extraordinaire Cathie Wood has had a rough 2021. The ARK Innovation ETF (NYSEMKT:ARKK) is down 38% off its all-...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/24/3-bargain-stocks-that-cathie-wood-loves/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SHOP":"Shopify Inc","COIN":"Coinbase Global, Inc.","PATH":"UiPath"},"source_url":"https://www.fool.com/investing/2021/12/24/3-bargain-stocks-that-cathie-wood-loves/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193178197","content_text":"After an astounding 2020, the chief investment officer of ARK Invest and stock picker extraordinaire Cathie Wood has had a rough 2021. The ARK Innovation ETF (NYSEMKT:ARKK) is down 38% off its all-time high and down 22% year to date.\nARK and Wood invest in lots of high-growth tech stocks that have been battered this year, which is what's causing the fund's poor performance. Coinbase Global (NASDAQ:COIN), Shopify (NYSE:SHOP), and UiPath (NYSE:PATH) are some of Cathie Wood's favorites, and all are between 20% and 50% off their all-time highs. However, the fact that millions of dollars of their stock are sitting in Wood's ETFs should be indicative of their long-term potential. These companies are trading at bargain prices today, so you might want to consider putting them on your watchlist.\nCoinbase: A way to invest in crypto\nCoinbase is ARK Invest's third-largest holding, clocking in at a market value of $1.25 billion. Shares of the world's largest cryptocurrency exchange have sunk like a stone recently, falling 32% off its all-time highs. However, this isn't fully indicative of business performance.\nWith over $255 billion in assets across 100 different countries and 72 million users, Coinbase has become a cornerstone of the crypto economy as one of the leading, most trusted cryptocurrency exchanges. The company takes a cut of every purchase of crypto on the platform, so the rise in popularity of cryptocurrency has resulted in impressive revenue success. The company's revenue increased by over 330% year over year in Q3. With this, the company has also achieved impressive profitability: Coinbase brought almost one-third of its revenue to the bottom line.\nWhile its reliance on cryptocurrencies like Bitcoin (CRYPTO:BTC) has led to amazing growth recently, it's really a double-edged sword. The company makes money only on purchases of crypto, so in large-scale crypto sell-offs, the company is left stranded. This leaves Coinbase largely vulnerable to the winds of the crypto markets.\nWith the recent sell-off of crypto and Bitcoin, Coinbase has followed suit -- falling to a valuation of just 22 times earnings. Whether this is justified or not, Coinbase will likely mimic the crypto market, and its success largely depends on the widespread adoption of crypto. Therefore, if you think that cryptocurrencies will skyrocket over the next decade, Coinbase could be a smart investment.\nUiPath: An AI pureplay\nWhile not as large as Coinbase, ARK ETFs hold over $1 billion of UiPath stock -- making it the sixth-largest holding across all of Wood's funds. UiPath is disrupting the way companies operate and handle tedious, repetitive tasks by normalizing the use of artificial intelligence and bots. The company has the vision to deliver a fully automated enterprise so that workers can optimize their efficiency, and the way the company is doing this has attracted companies like AutoDesk (NASDAQ:ADSK) and NASA.\nWhile UiPath's product sounds like a pie-in-the-sky dream, the company is more than real. It has over 9,600 customers and $818 million in annual recurring revenue (ARR). With such dominance, UiPath has been named a market leader in the robotic process automation (RPA) market in Gartner's Magic Quadrant. As the leader, it has gained the trust and confidence of companies that might be wary of bringing automation and robots into the workplace.\nUiPath has lots of potential to grow. The company sees a $30 billion addressable opportunity by 2024, which would be immense growth from its current $818 million in ARR. UiPath might get some pushback along the way from those wary of integrating robots into the workplace, but its robots can provide efficiency improvements. The company has saved its customers millions of hours and dollars without putting workers' jobs on the line. UiPath is meant to work alongside human employees, and it has been successful in doing so.\nShares have fallen drastically since it came public earlier this year, and that has provided a valuation that an appealing valuation public at 60 times sales, but it now trades at 22 times sales. Cathie Wood has taken the opportunity to buy more shares this December, and you might want to consider doing the same.\nShopify: The rising e-commerce pick\nShopify is farther down at the 11th-largest ARK position, but still represents $950 million worth of shares -- and for good reason. The company has doubled its gross merchandise volume (GMV) over the past 16 months, reaching $400 billion in cumulative GMV on its merchants' platforms in Q3. This has been because of the company's relentless focus on its customers' growth and success. This is unrivaled by competitors like Amazon (NASDAQ:AMZN), which have often stifled SMBs by noticing their success and then offering and promoting a self-developed product that competes with them directly.\nThe company recently announced a new feature that would make international sales easier for merchants. Shopify Markets would allow companies to streamline global expansion -- something many Shopify users might never have thought possible. The company also has plans to roll out additional features over the next few years, with one of my personal favorites being Shopify Fulfillment. With this, users could access the fulfillment network that Shopify is building out and let the company pack and ship orders for them.\nThis focus on customer success is truly unique, which is why the company demands a very high premium. The company trades at roughly 40 times sales, which is the highest valuation out of these three stocks. However, I also believe that Shopify is the highest-quality stock on this list. While all three of these stocks are appealing, Shopify has proven itself the most, and the company's expansion efforts beyond SMB look very promising. While there is more risk that share prices could continue dropping, I think it is worth paying up for high-quality companies, and Shopify fits that bill. Given the number of shares that Cathie Wood owns, I think she is in agreement.","news_type":1},"isVote":1,"tweetType":1,"viewCount":552,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691605784,"gmtCreate":1640178479190,"gmtModify":1640178479287,"author":{"id":"3580859173247698","authorId":"3580859173247698","name":"ChewWeiKiat","avatar":"https://static.tigerbbs.com/131da1c18d7a77a7044724a63dbc30f8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580859173247698","authorIdStr":"3580859173247698"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691605784","repostId":"1123940793","repostType":4,"isVote":1,"tweetType":1,"viewCount":745,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605897047,"gmtCreate":1639141489632,"gmtModify":1639141489632,"author":{"id":"3580859173247698","authorId":"3580859173247698","name":"ChewWeiKiat","avatar":"https://static.tigerbbs.com/131da1c18d7a77a7044724a63dbc30f8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580859173247698","authorIdStr":"3580859173247698"},"themes":[],"htmlText":"The market is unstable now[微笑] [呆住] ","listText":"The market is unstable now[微笑] [呆住] ","text":"The market is unstable now[微笑] [呆住]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/605897047","repostId":"1115031273","repostType":4,"isVote":1,"tweetType":1,"viewCount":864,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":605897047,"gmtCreate":1639141489632,"gmtModify":1639141489632,"author":{"id":"3580859173247698","authorId":"3580859173247698","name":"ChewWeiKiat","avatar":"https://static.tigerbbs.com/131da1c18d7a77a7044724a63dbc30f8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580859173247698","authorIdStr":"3580859173247698"},"themes":[],"htmlText":"The market is unstable now[微笑] [呆住] ","listText":"The market is unstable now[微笑] [呆住] ","text":"The market is unstable now[微笑] [呆住]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/605897047","repostId":"1115031273","repostType":4,"repost":{"id":"1115031273","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639143317,"share":"https://www.laohu8.com/m/news/1115031273?lang=&edition=full","pubTime":"2021-12-10 21:35","market":"us","language":"en","title":"Toplines Before US Market Open on Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1115031273","media":"Tiger Newspress","summary":"Stock-market index trade higher after inflation report.\nAt 8:34 a.m. ET, Dow e-minis were up 176 poi","content":"<p>Stock-market index trade higher after inflation report.</p>\n<p>At 8:34 a.m. ET, Dow e-minis were up 176 points, or 0.49%, S&P 500 e-minis were up 30.75 points, or 0.66%, and Nasdaq 100 e-minis were up 115.25 points, or 0.71%.</p>\n<p><img src=\"https://static.tigerbbs.com/022d770c8d408fcc5c7a5267e1fa96a1\" tg-width=\"412\" tg-height=\"184\" referrerpolicy=\"no-referrer\"></p>\n<p>Inflation accelerated at its fastest pace since 1982 in November, the Labor Department said Friday, putting pressure on the economic recovery and raising the stakes for the Federal Reserve.</p>\n<p>The consumer price index, which measures the cost of a wide-ranging basket of goods, rose 0.8% for the month, good for a 6.8% pace on a year over year basis and the fastest rate since June 1982.</p>\n<p>Excluding food and energy prices, so-called core CPI was up 0.5% for the month and 4.9% from a year ago, which itself was the sharpest pickup since mid-1991.</p>\n<p>The Dow Jones estimate was for a 6.7% annual gain for headline CPI and 4.9% for core.</p>\n<p><b>Stocks making the biggest moves premarket:</b></p>\n<p><b>Tesla(TSLA)</b> – Tesla Inc Chief Executive Officer Elon Musk has sold another 934,091 shares of the electric vehicle maker worth $963.2 million, U.S. securities filings showed on Thursday.He also exercised stock options to buy 2.17 million shares of Tesla, according to the filings.Musk is \"thinking of\" leaving his jobs and becoming an influencer, the world's richest man tweeted on Thursday.It was not immediately clear if Musk, a prolific user of the social media platform, was being serious about quitting his roles.Tesla shares dropped more than 1% in premarket trading.</p>\n<p><b>Oracle(ORCL) </b>– Oracle shares surged 12% in the premarket, after quarterly sales and revenue beat estimates and the business software company announced a $10 billion increase in its share repurchase program. Oracle earned an adjusted $1.21 per share, 10 cents above estimates, with particular strength for its cloud infrastructure business.</p>\n<p><b>Broadcom(AVGO)</b> – The chip maker’s shares rallied nearly 7% in premarket trading after it beat Street forecasts on the top and bottom lines for its latest quarter. Broadcom earned an adjusted $7.81 per share, 7 cents above estimates, and also issued an upbeat forecast on continued high demand from its cloud computing customers.</p>\n<p><b>Chewy(CHWY) </b>– The online pet products retailer’s stock tumbled 10% in the premarket after it reported a wider-than-expected quarterly loss. Sales were in line with Street forecasts, but profit was impacted by higher costs for labor and supply chain issues.</p>\n<p><b>Moderna(MRNA)</b> – Moderna shares plunged 10% in premarket trading.Other vaccine stocks also fell.BioNTech fell more than 5%,Novavax fell more than 3%.</p>\n<p><b>Lululemon(LULU)</b> – The athletic apparel maker reported adjusted quarterly profit of $1.62 per share, 21 cents above estimates, with revenue slightly above forecasts as well. However, Lululemon also warned that new Covid-19 variants could impact demand for “athleisure” clothing if virus concerns lead to temporary store closures and further supply chain issues. The stock slid 1.3% in premarket action.</p>\n<p><b>C3Ai(AI)</b> – The artificial intelligence software company’s stock soared 20% in the premarket after it won a $500 million contract from the U.S. Department of Defense for its suite of AI products.</p>\n<p><b>Costco(COST)</b> – The warehouse retailer earned $2.98 per share for its latest quarter, compared with a consensus estimate of $2.64, with revenue topping Street forecasts as well. The beat came despite higher costs and supply chain issues that Costco said it was able to largely mitigate. Costco rose 1.8% in the premarket.</p>\n<p><b>Beyond Meat(BYND)</b> – Restaurant chain Taco Bell dropped plans to test Beyond Meat’s plant-based version of carne asada,according to a Bloomberg report. Taco Bell is said to have been dissatisfied with samples it received in October, although the companies continue to work together on new products. Beyond Meat slipped 1.6% in premarket trading.</p>\n<p><b>American Outdoor Brands(AOUT)</b> – The outdoor products maker reported adjusted quarterly profit of 58 cents per share, well below the 76 cent consensus estimate, with revenue also falling short of analyst forecasts. The company said sales slowed due to a shift in customer purchase timing into the prior quarter to lessen supply chain concerns. American Outdoor shares plummeted 19% in premarket action.</p>\n<p><b>Vail Resorts(MTN)</b> – The resort operator lost $3.44 per share for its latest quarter, smaller than the loss of $3.62 that analysts had anticipated, thanks to a jump in season pass sales. However, revenue was below estimates.</p>\n<p><b>Peloton(PTON)</b> – The fitness equipment maker’s shares lost 3.6% in the premarket after Credit Suisse downgraded the stock to “neutral” from “outperform”. The firm noted a number of headwinds for Peloton, including a return to out-of-home fitness and a shift in consumer spending.</p>\n<p><b>AMC Entertainment(AMC)</b> – The movie theater operator’s shares slid 1% in premarket trading, after SEC filings showed a sale of 312,500 shares by CEO Adam Aron and a sale of 18,000 shares by CFO Sean Goodman. Aron had indicated in November that he would soon begin selling shares as part of estate planning.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-10 21:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Stock-market index trade higher after inflation report.</p>\n<p>At 8:34 a.m. ET, Dow e-minis were up 176 points, or 0.49%, S&P 500 e-minis were up 30.75 points, or 0.66%, and Nasdaq 100 e-minis were up 115.25 points, or 0.71%.</p>\n<p><img src=\"https://static.tigerbbs.com/022d770c8d408fcc5c7a5267e1fa96a1\" tg-width=\"412\" tg-height=\"184\" referrerpolicy=\"no-referrer\"></p>\n<p>Inflation accelerated at its fastest pace since 1982 in November, the Labor Department said Friday, putting pressure on the economic recovery and raising the stakes for the Federal Reserve.</p>\n<p>The consumer price index, which measures the cost of a wide-ranging basket of goods, rose 0.8% for the month, good for a 6.8% pace on a year over year basis and the fastest rate since June 1982.</p>\n<p>Excluding food and energy prices, so-called core CPI was up 0.5% for the month and 4.9% from a year ago, which itself was the sharpest pickup since mid-1991.</p>\n<p>The Dow Jones estimate was for a 6.7% annual gain for headline CPI and 4.9% for core.</p>\n<p><b>Stocks making the biggest moves premarket:</b></p>\n<p><b>Tesla(TSLA)</b> – Tesla Inc Chief Executive Officer Elon Musk has sold another 934,091 shares of the electric vehicle maker worth $963.2 million, U.S. securities filings showed on Thursday.He also exercised stock options to buy 2.17 million shares of Tesla, according to the filings.Musk is \"thinking of\" leaving his jobs and becoming an influencer, the world's richest man tweeted on Thursday.It was not immediately clear if Musk, a prolific user of the social media platform, was being serious about quitting his roles.Tesla shares dropped more than 1% in premarket trading.</p>\n<p><b>Oracle(ORCL) </b>– Oracle shares surged 12% in the premarket, after quarterly sales and revenue beat estimates and the business software company announced a $10 billion increase in its share repurchase program. Oracle earned an adjusted $1.21 per share, 10 cents above estimates, with particular strength for its cloud infrastructure business.</p>\n<p><b>Broadcom(AVGO)</b> – The chip maker’s shares rallied nearly 7% in premarket trading after it beat Street forecasts on the top and bottom lines for its latest quarter. Broadcom earned an adjusted $7.81 per share, 7 cents above estimates, and also issued an upbeat forecast on continued high demand from its cloud computing customers.</p>\n<p><b>Chewy(CHWY) </b>– The online pet products retailer’s stock tumbled 10% in the premarket after it reported a wider-than-expected quarterly loss. Sales were in line with Street forecasts, but profit was impacted by higher costs for labor and supply chain issues.</p>\n<p><b>Moderna(MRNA)</b> – Moderna shares plunged 10% in premarket trading.Other vaccine stocks also fell.BioNTech fell more than 5%,Novavax fell more than 3%.</p>\n<p><b>Lululemon(LULU)</b> – The athletic apparel maker reported adjusted quarterly profit of $1.62 per share, 21 cents above estimates, with revenue slightly above forecasts as well. However, Lululemon also warned that new Covid-19 variants could impact demand for “athleisure” clothing if virus concerns lead to temporary store closures and further supply chain issues. The stock slid 1.3% in premarket action.</p>\n<p><b>C3Ai(AI)</b> – The artificial intelligence software company’s stock soared 20% in the premarket after it won a $500 million contract from the U.S. Department of Defense for its suite of AI products.</p>\n<p><b>Costco(COST)</b> – The warehouse retailer earned $2.98 per share for its latest quarter, compared with a consensus estimate of $2.64, with revenue topping Street forecasts as well. The beat came despite higher costs and supply chain issues that Costco said it was able to largely mitigate. Costco rose 1.8% in the premarket.</p>\n<p><b>Beyond Meat(BYND)</b> – Restaurant chain Taco Bell dropped plans to test Beyond Meat’s plant-based version of carne asada,according to a Bloomberg report. Taco Bell is said to have been dissatisfied with samples it received in October, although the companies continue to work together on new products. Beyond Meat slipped 1.6% in premarket trading.</p>\n<p><b>American Outdoor Brands(AOUT)</b> – The outdoor products maker reported adjusted quarterly profit of 58 cents per share, well below the 76 cent consensus estimate, with revenue also falling short of analyst forecasts. The company said sales slowed due to a shift in customer purchase timing into the prior quarter to lessen supply chain concerns. American Outdoor shares plummeted 19% in premarket action.</p>\n<p><b>Vail Resorts(MTN)</b> – The resort operator lost $3.44 per share for its latest quarter, smaller than the loss of $3.62 that analysts had anticipated, thanks to a jump in season pass sales. However, revenue was below estimates.</p>\n<p><b>Peloton(PTON)</b> – The fitness equipment maker’s shares lost 3.6% in the premarket after Credit Suisse downgraded the stock to “neutral” from “outperform”. The firm noted a number of headwinds for Peloton, including a return to out-of-home fitness and a shift in consumer spending.</p>\n<p><b>AMC Entertainment(AMC)</b> – The movie theater operator’s shares slid 1% in premarket trading, after SEC filings showed a sale of 312,500 shares by CEO Adam Aron and a sale of 18,000 shares by CFO Sean Goodman. Aron had indicated in November that he would soon begin selling shares as part of estate planning.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","PTON":"Peloton Interactive, Inc.","ORCL":"甲骨文","BYND":"Beyond Meat, Inc.","NVAX":"诺瓦瓦克斯医药",".IXIC":"NASDAQ Composite","AMC":"AMC院线","AOUT":"American Outdoor Brands, Inc.","CHWY":"Chewy, Inc.",".SPX":"S&P 500 Index","AI":"C3.ai, Inc.","TSLA":"特斯拉","LULU":"lululemon athletica","AVGO":"博通","COST":"好市多","MRNA":"Moderna, Inc.","MTN":"Vail Resorts Inc",".DJI":"道琼斯"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1115031273","content_text":"Stock-market index trade higher after inflation report.\nAt 8:34 a.m. ET, Dow e-minis were up 176 points, or 0.49%, S&P 500 e-minis were up 30.75 points, or 0.66%, and Nasdaq 100 e-minis were up 115.25 points, or 0.71%.\n\nInflation accelerated at its fastest pace since 1982 in November, the Labor Department said Friday, putting pressure on the economic recovery and raising the stakes for the Federal Reserve.\nThe consumer price index, which measures the cost of a wide-ranging basket of goods, rose 0.8% for the month, good for a 6.8% pace on a year over year basis and the fastest rate since June 1982.\nExcluding food and energy prices, so-called core CPI was up 0.5% for the month and 4.9% from a year ago, which itself was the sharpest pickup since mid-1991.\nThe Dow Jones estimate was for a 6.7% annual gain for headline CPI and 4.9% for core.\nStocks making the biggest moves premarket:\nTesla(TSLA) – Tesla Inc Chief Executive Officer Elon Musk has sold another 934,091 shares of the electric vehicle maker worth $963.2 million, U.S. securities filings showed on Thursday.He also exercised stock options to buy 2.17 million shares of Tesla, according to the filings.Musk is \"thinking of\" leaving his jobs and becoming an influencer, the world's richest man tweeted on Thursday.It was not immediately clear if Musk, a prolific user of the social media platform, was being serious about quitting his roles.Tesla shares dropped more than 1% in premarket trading.\nOracle(ORCL) – Oracle shares surged 12% in the premarket, after quarterly sales and revenue beat estimates and the business software company announced a $10 billion increase in its share repurchase program. Oracle earned an adjusted $1.21 per share, 10 cents above estimates, with particular strength for its cloud infrastructure business.\nBroadcom(AVGO) – The chip maker’s shares rallied nearly 7% in premarket trading after it beat Street forecasts on the top and bottom lines for its latest quarter. Broadcom earned an adjusted $7.81 per share, 7 cents above estimates, and also issued an upbeat forecast on continued high demand from its cloud computing customers.\nChewy(CHWY) – The online pet products retailer’s stock tumbled 10% in the premarket after it reported a wider-than-expected quarterly loss. Sales were in line with Street forecasts, but profit was impacted by higher costs for labor and supply chain issues.\nModerna(MRNA) – Moderna shares plunged 10% in premarket trading.Other vaccine stocks also fell.BioNTech fell more than 5%,Novavax fell more than 3%.\nLululemon(LULU) – The athletic apparel maker reported adjusted quarterly profit of $1.62 per share, 21 cents above estimates, with revenue slightly above forecasts as well. However, Lululemon also warned that new Covid-19 variants could impact demand for “athleisure” clothing if virus concerns lead to temporary store closures and further supply chain issues. The stock slid 1.3% in premarket action.\nC3Ai(AI) – The artificial intelligence software company’s stock soared 20% in the premarket after it won a $500 million contract from the U.S. Department of Defense for its suite of AI products.\nCostco(COST) – The warehouse retailer earned $2.98 per share for its latest quarter, compared with a consensus estimate of $2.64, with revenue topping Street forecasts as well. The beat came despite higher costs and supply chain issues that Costco said it was able to largely mitigate. Costco rose 1.8% in the premarket.\nBeyond Meat(BYND) – Restaurant chain Taco Bell dropped plans to test Beyond Meat’s plant-based version of carne asada,according to a Bloomberg report. Taco Bell is said to have been dissatisfied with samples it received in October, although the companies continue to work together on new products. Beyond Meat slipped 1.6% in premarket trading.\nAmerican Outdoor Brands(AOUT) – The outdoor products maker reported adjusted quarterly profit of 58 cents per share, well below the 76 cent consensus estimate, with revenue also falling short of analyst forecasts. The company said sales slowed due to a shift in customer purchase timing into the prior quarter to lessen supply chain concerns. American Outdoor shares plummeted 19% in premarket action.\nVail Resorts(MTN) – The resort operator lost $3.44 per share for its latest quarter, smaller than the loss of $3.62 that analysts had anticipated, thanks to a jump in season pass sales. However, revenue was below estimates.\nPeloton(PTON) – The fitness equipment maker’s shares lost 3.6% in the premarket after Credit Suisse downgraded the stock to “neutral” from “outperform”. The firm noted a number of headwinds for Peloton, including a return to out-of-home fitness and a shift in consumer spending.\nAMC Entertainment(AMC) – The movie theater operator’s shares slid 1% in premarket trading, after SEC filings showed a sale of 312,500 shares by CEO Adam Aron and a sale of 18,000 shares by CFO Sean Goodman. Aron had indicated in November that he would soon begin selling shares as part of estate planning.","news_type":1},"isVote":1,"tweetType":1,"viewCount":864,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698444916,"gmtCreate":1640514110389,"gmtModify":1640514110440,"author":{"id":"3580859173247698","authorId":"3580859173247698","name":"ChewWeiKiat","avatar":"https://static.tigerbbs.com/131da1c18d7a77a7044724a63dbc30f8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580859173247698","authorIdStr":"3580859173247698"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/698444916","repostId":"2193178197","repostType":4,"repost":{"id":"2193178197","kind":"highlight","pubTimestamp":1640485804,"share":"https://www.laohu8.com/m/news/2193178197?lang=&edition=full","pubTime":"2021-12-26 10:30","market":"us","language":"en","title":"3 Bargain Stocks That Cathie Wood Loves","url":"https://stock-news.laohu8.com/highlight/detail?id=2193178197","media":"Motley Fool","summary":"Is now the best time to buy these three Wood picks?","content":"<p>After an astounding 2020, the chief investment officer of ARK Invest and stock picker extraordinaire Cathie Wood has had a rough 2021. The <b><a href=\"https://laohu8.com/S/ARKK\">ARK Innovation ETF</a></b> (NYSEMKT:ARKK) is down 38% off its all-time high and down 22% year to date.</p>\n<p>ARK and Wood invest in lots of high-growth tech stocks that have been battered this year, which is what's causing the fund's poor performance. <b>Coinbase Global</b> (NASDAQ:COIN), <b>Shopify</b> (NYSE:SHOP), and <b><a href=\"https://laohu8.com/S/PATH\">UiPath</a></b> (NYSE:PATH) are some of Cathie Wood's favorites, and all are between 20% and 50% off their all-time highs. However, the fact that millions of dollars of their stock are sitting in Wood's ETFs should be indicative of their long-term potential. These companies are trading at bargain prices today, so you might want to consider putting them on your watchlist.</p>\n<h2>Coinbase: A way to invest in crypto</h2>\n<p>Coinbase is ARK Invest's third-largest holding, clocking in at a market value of $1.25 billion. Shares of the world's largest cryptocurrency exchange have sunk like a stone recently, falling 32% off its all-time highs. However, this isn't fully indicative of business performance.</p>\n<p>With over $255 billion in assets across 100 different countries and 72 million users, Coinbase has become a cornerstone of the crypto economy as <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the leading, most trusted cryptocurrency exchanges. The company takes a cut of every purchase of crypto on the platform, so the rise in popularity of cryptocurrency has resulted in impressive revenue success. The company's revenue increased by over 330% year over year in Q3. With this, the company has also achieved impressive profitability: Coinbase brought almost one-third of its revenue to the bottom line.</p>\n<p>While its reliance on cryptocurrencies like <b>Bitcoin</b> (CRYPTO:BTC) has led to amazing growth recently, it's really a double-edged sword. The company makes money only on purchases of crypto, so in large-scale crypto sell-offs, the company is left stranded. This leaves Coinbase largely vulnerable to the winds of the crypto markets.</p>\n<p>With the recent sell-off of crypto and Bitcoin, Coinbase has followed suit -- falling to a valuation of just 22 times earnings. Whether this is justified or not, Coinbase will likely mimic the crypto market, and its success largely depends on the widespread adoption of crypto. Therefore, if you think that cryptocurrencies will skyrocket over the next decade, Coinbase could be a smart investment.</p>\n<h2>UiPath: An AI pureplay</h2>\n<p>While not as large as Coinbase, ARK ETFs hold over $1 billion of UiPath stock -- making it the sixth-largest holding across all of Wood's funds. UiPath is disrupting the way companies operate and handle tedious, repetitive tasks by normalizing the use of artificial intelligence and bots. The company has the vision to deliver a fully automated enterprise so that workers can optimize their efficiency, and the way the company is doing this has attracted companies like <b>AutoDesk</b> (NASDAQ:ADSK) and NASA.</p>\n<p>While UiPath's product sounds like a pie-in-the-sky dream, the company is more than real. It has over 9,600 customers and $818 million in annual recurring revenue (ARR). With such dominance, UiPath has been named a market leader in the robotic process automation (RPA) market in <b>Gartner</b>'s Magic Quadrant. As the leader, it has gained the trust and confidence of companies that might be wary of bringing automation and robots into the workplace.</p>\n<p>UiPath has lots of potential to grow. The company sees a $30 billion addressable opportunity by 2024, which would be immense growth from its current $818 million in ARR. UiPath might get some pushback along the way from those wary of integrating robots into the workplace, but its robots can provide efficiency improvements. The company has saved its customers millions of hours and dollars without putting workers' jobs on the line. UiPath is meant to work alongside human employees, and it has been successful in doing so.</p>\n<p>Shares have fallen drastically since it came public earlier this year, and that has provided a valuation that an appealing valuation public at 60 times sales, but it now trades at 22 times sales. Cathie Wood has taken the opportunity to buy more shares this December, and you might want to consider doing the same.</p>\n<h2>Shopify: The rising e-commerce pick</h2>\n<p>Shopify is farther down at the 11th-largest ARK position, but still represents $950 million worth of shares -- and for good reason. The company has doubled its gross merchandise volume (GMV) over the past 16 months, reaching $400 billion in cumulative GMV on its merchants' platforms in Q3. This has been because of the company's relentless focus on its customers' growth and success. This is unrivaled by competitors like <b>Amazon</b> (NASDAQ:AMZN), which have often stifled SMBs by noticing their success and then offering and promoting a self-developed product that competes with them directly.</p>\n<p>The company recently announced a new feature that would make international sales easier for merchants. Shopify Markets would allow companies to streamline global expansion -- something many Shopify users might never have thought possible. The company also has plans to roll out additional features over the next few years, with one of my personal favorites being Shopify Fulfillment. With this, users could access the fulfillment network that Shopify is building out and let the company pack and ship orders for them.</p>\n<p>This focus on customer success is truly unique, which is why the company demands a very high premium. The company trades at roughly 40 times sales, which is the highest valuation out of these three stocks. However, I also believe that Shopify is the highest-quality stock on this list. While all three of these stocks are appealing, Shopify has proven itself the most, and the company's expansion efforts beyond SMB look very promising. While there is more risk that share prices could continue dropping, I think it is worth paying up for high-quality companies, and Shopify fits that bill. Given the number of shares that Cathie Wood owns, I think she is in agreement.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Bargain Stocks That Cathie Wood Loves</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Bargain Stocks That Cathie Wood Loves\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-26 10:30 GMT+8 <a href=https://www.fool.com/investing/2021/12/24/3-bargain-stocks-that-cathie-wood-loves/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After an astounding 2020, the chief investment officer of ARK Invest and stock picker extraordinaire Cathie Wood has had a rough 2021. The ARK Innovation ETF (NYSEMKT:ARKK) is down 38% off its all-...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/24/3-bargain-stocks-that-cathie-wood-loves/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SHOP":"Shopify Inc","COIN":"Coinbase Global, Inc.","PATH":"UiPath"},"source_url":"https://www.fool.com/investing/2021/12/24/3-bargain-stocks-that-cathie-wood-loves/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193178197","content_text":"After an astounding 2020, the chief investment officer of ARK Invest and stock picker extraordinaire Cathie Wood has had a rough 2021. The ARK Innovation ETF (NYSEMKT:ARKK) is down 38% off its all-time high and down 22% year to date.\nARK and Wood invest in lots of high-growth tech stocks that have been battered this year, which is what's causing the fund's poor performance. Coinbase Global (NASDAQ:COIN), Shopify (NYSE:SHOP), and UiPath (NYSE:PATH) are some of Cathie Wood's favorites, and all are between 20% and 50% off their all-time highs. However, the fact that millions of dollars of their stock are sitting in Wood's ETFs should be indicative of their long-term potential. These companies are trading at bargain prices today, so you might want to consider putting them on your watchlist.\nCoinbase: A way to invest in crypto\nCoinbase is ARK Invest's third-largest holding, clocking in at a market value of $1.25 billion. Shares of the world's largest cryptocurrency exchange have sunk like a stone recently, falling 32% off its all-time highs. However, this isn't fully indicative of business performance.\nWith over $255 billion in assets across 100 different countries and 72 million users, Coinbase has become a cornerstone of the crypto economy as one of the leading, most trusted cryptocurrency exchanges. The company takes a cut of every purchase of crypto on the platform, so the rise in popularity of cryptocurrency has resulted in impressive revenue success. The company's revenue increased by over 330% year over year in Q3. With this, the company has also achieved impressive profitability: Coinbase brought almost one-third of its revenue to the bottom line.\nWhile its reliance on cryptocurrencies like Bitcoin (CRYPTO:BTC) has led to amazing growth recently, it's really a double-edged sword. The company makes money only on purchases of crypto, so in large-scale crypto sell-offs, the company is left stranded. This leaves Coinbase largely vulnerable to the winds of the crypto markets.\nWith the recent sell-off of crypto and Bitcoin, Coinbase has followed suit -- falling to a valuation of just 22 times earnings. Whether this is justified or not, Coinbase will likely mimic the crypto market, and its success largely depends on the widespread adoption of crypto. Therefore, if you think that cryptocurrencies will skyrocket over the next decade, Coinbase could be a smart investment.\nUiPath: An AI pureplay\nWhile not as large as Coinbase, ARK ETFs hold over $1 billion of UiPath stock -- making it the sixth-largest holding across all of Wood's funds. UiPath is disrupting the way companies operate and handle tedious, repetitive tasks by normalizing the use of artificial intelligence and bots. The company has the vision to deliver a fully automated enterprise so that workers can optimize their efficiency, and the way the company is doing this has attracted companies like AutoDesk (NASDAQ:ADSK) and NASA.\nWhile UiPath's product sounds like a pie-in-the-sky dream, the company is more than real. It has over 9,600 customers and $818 million in annual recurring revenue (ARR). With such dominance, UiPath has been named a market leader in the robotic process automation (RPA) market in Gartner's Magic Quadrant. As the leader, it has gained the trust and confidence of companies that might be wary of bringing automation and robots into the workplace.\nUiPath has lots of potential to grow. The company sees a $30 billion addressable opportunity by 2024, which would be immense growth from its current $818 million in ARR. UiPath might get some pushback along the way from those wary of integrating robots into the workplace, but its robots can provide efficiency improvements. The company has saved its customers millions of hours and dollars without putting workers' jobs on the line. UiPath is meant to work alongside human employees, and it has been successful in doing so.\nShares have fallen drastically since it came public earlier this year, and that has provided a valuation that an appealing valuation public at 60 times sales, but it now trades at 22 times sales. Cathie Wood has taken the opportunity to buy more shares this December, and you might want to consider doing the same.\nShopify: The rising e-commerce pick\nShopify is farther down at the 11th-largest ARK position, but still represents $950 million worth of shares -- and for good reason. The company has doubled its gross merchandise volume (GMV) over the past 16 months, reaching $400 billion in cumulative GMV on its merchants' platforms in Q3. This has been because of the company's relentless focus on its customers' growth and success. This is unrivaled by competitors like Amazon (NASDAQ:AMZN), which have often stifled SMBs by noticing their success and then offering and promoting a self-developed product that competes with them directly.\nThe company recently announced a new feature that would make international sales easier for merchants. Shopify Markets would allow companies to streamline global expansion -- something many Shopify users might never have thought possible. The company also has plans to roll out additional features over the next few years, with one of my personal favorites being Shopify Fulfillment. With this, users could access the fulfillment network that Shopify is building out and let the company pack and ship orders for them.\nThis focus on customer success is truly unique, which is why the company demands a very high premium. The company trades at roughly 40 times sales, which is the highest valuation out of these three stocks. However, I also believe that Shopify is the highest-quality stock on this list. While all three of these stocks are appealing, Shopify has proven itself the most, and the company's expansion efforts beyond SMB look very promising. While there is more risk that share prices could continue dropping, I think it is worth paying up for high-quality companies, and Shopify fits that bill. Given the number of shares that Cathie Wood owns, I think she is in agreement.","news_type":1},"isVote":1,"tweetType":1,"viewCount":552,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698444160,"gmtCreate":1640514148243,"gmtModify":1640514148243,"author":{"id":"3580859173247698","authorId":"3580859173247698","name":"ChewWeiKiat","avatar":"https://static.tigerbbs.com/131da1c18d7a77a7044724a63dbc30f8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580859173247698","authorIdStr":"3580859173247698"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/698444160","repostId":"2193781141","repostType":4,"repost":{"id":"2193781141","kind":"highlight","pubTimestamp":1640485676,"share":"https://www.laohu8.com/m/news/2193781141?lang=&edition=full","pubTime":"2021-12-26 10:27","market":"us","language":"en","title":"2 Top Tech Stocks to Buy During a Recession","url":"https://stock-news.laohu8.com/highlight/detail?id=2193781141","media":"Motley Fool","summary":"Market crashes are inevitable, but they're the perfect time to buy great businesses at a discount.","content":"<p>We're days away from the end of 2021, and the <b>S&P 500</b> has put on a master class in outperforming expectations. Even with its pullback in recent days, the broad market index has gained nearly 30% this year, more than double its long-term historical average.</p>\n<p>Yet that just means we're another day closer to the inevitable market correction. Just as night follows day, a stock market crash is inevitable because market declines are a natural part of the normal business and investment cycle. No <a href=\"https://laohu8.com/S/AONE.U\">one</a> can forecast exactly when it will strike, but smart investors realize it's best to prepare for the eventuality.</p>\n<p>For as long as people have been investing, stretching even as far back to the Dutch tulip mania in the 1600s, busts have followed booms. And what a boom we've enjoyed! Since the bottom of the Great Recession, the S&P 500 has quadrupled in value.</p>\n<p>2020's pandemic-driven 34% drop in the stock indexes within the span of just a few weeks was the worst on record. But savvy investors don't have to worry. These events are not a problem when you're invested in the right companies. Being prepared for the worst and hoping for the best means when the next stock market crash or correction occurs, you'll want to have your money invested in stocks that will help lead the way forward. Here are two tech stocks you'll want to buy.</p>\n<h2>1. Apple</h2>\n<p>The burden that inflation is imposing on consumers also poses a threat to some of the biggest, best-run businesses, like <b>Apple</b> (NASDAQ:AAPL), which is currently benefiting from the smartphone upgrade cycle and the rollout of 5G network infrastructure. Any attempt by the Federal Reserve to raise interest rates to contain runaway inflation could cause an economic slowdown by making money more expensive to borrow. Stock valuations would also turn lower.</p>\n<p>That's not necessarily bad news for investors who might find Apple's $2.8 trillion valuation a bit rich to buy into at the moment. The stock trades at 30 times trailing earnings, or about double its typical multiple. A correction would bring Apple back into the realm of the attainable, even as its business continues jogging forward.</p>\n<p>Sales of the iPhone 13 are outpacing those of the iPhone 12 at the same time, but Apple reportedly warned suppliers that demand is waning as the calendar year progresses. It's not necessarily for a lack of consumer desire, but rather the global supply chain constraints that have made it difficult to find the product. Apple previously cut its iPhone production target by 10 million units from its original goal of 90 million.</p>\n<p>Analysts think many consumers may choose to forgo the iPhone 13 and wait for the next upgrade. Coupled with a market crash, that could put Apple stock at a very attractive entry point with pent-up demand for the next iteration of the iPhone.</p>\n<h2>2. Amazon</h2>\n<p>Few companies are as essential to the working of the U.S. economy as <b>Amazon</b> (NASDAQ:AMZN). It will account for 41.4% of all online spending in the U.S. this year, according to eMarketer estimates. At the same time, Amazon Web Services (AWS), its cloud infrastructure business, is on track to generate over $60 billion in annual revenue in 2021 based on its year-to-date performance. The company is responsible for thousands of web-based businesses and the federal government's ability to remain online, making Amazon crucial to a well-functioning economy.</p>\n<p>That won't change if the stock market collapses. Its share of U.S. retail e-commerce sales will be more than 50% larger than the shares of the next nine e-commerce companies combined. Amazon's piece of the online market is nearly six times more than <b>Walmart</b>'s second-place share at just 7.2%, and 10 times greater than third-place <b><a href=\"https://laohu8.com/S/EBAY\">eBay</a></b>. E-commerce data tracker Edge by Ascential expects Amazon will see $26.7 billion just in online grocery sales five from now years, or nearly double its current amount.</p>\n<p>Amid rising prices and supply chain woes, Amazon has become a lifeline for many, and that will continue long after any financial restructuring. The stock gained 76% during the first year of the pandemic and took a breather during the reopening of the economy. Amazon shares have been relatively flat all year long. A correction would allow investors to buy a tech stock at a more reasonable valuation even as its crucial role only gets reinforced.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Top Tech Stocks to Buy During a Recession</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Top Tech Stocks to Buy During a Recession\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-26 10:27 GMT+8 <a href=https://www.fool.com/investing/2021/12/24/2-top-tech-stocks-to-buy-during-a-recession/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>We're days away from the end of 2021, and the S&P 500 has put on a master class in outperforming expectations. Even with its pullback in recent days, the broad market index has gained nearly 30% ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/24/2-top-tech-stocks-to-buy-during-a-recession/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊","BK4515":"5G概念","BK4554":"元宇宙及AR概念","BK4532":"文艺复兴科技持仓","BK4553":"喜马拉雅资本持仓","BK4507":"流媒体概念","BK4534":"瑞士信贷持仓","AAPL":"苹果","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4566":"资本集团","BK4535":"淡马锡持仓","BK4524":"宅经济概念","BK4527":"明星科技股","BK4538":"云计算","BK4559":"巴菲特持仓","BK4501":"段永平概念","BK4550":"红杉资本持仓","BK4503":"景林资产持仓","BK4122":"互联网与直销零售","BK4551":"寇图资本持仓","BK4561":"索罗斯持仓","BK4505":"高瓴资本持仓","BK4548":"巴美列捷福持仓","BK4170":"电脑硬件、储存设备及电脑周边"},"source_url":"https://www.fool.com/investing/2021/12/24/2-top-tech-stocks-to-buy-during-a-recession/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193781141","content_text":"We're days away from the end of 2021, and the S&P 500 has put on a master class in outperforming expectations. Even with its pullback in recent days, the broad market index has gained nearly 30% this year, more than double its long-term historical average.\nYet that just means we're another day closer to the inevitable market correction. Just as night follows day, a stock market crash is inevitable because market declines are a natural part of the normal business and investment cycle. No one can forecast exactly when it will strike, but smart investors realize it's best to prepare for the eventuality.\nFor as long as people have been investing, stretching even as far back to the Dutch tulip mania in the 1600s, busts have followed booms. And what a boom we've enjoyed! Since the bottom of the Great Recession, the S&P 500 has quadrupled in value.\n2020's pandemic-driven 34% drop in the stock indexes within the span of just a few weeks was the worst on record. But savvy investors don't have to worry. These events are not a problem when you're invested in the right companies. Being prepared for the worst and hoping for the best means when the next stock market crash or correction occurs, you'll want to have your money invested in stocks that will help lead the way forward. Here are two tech stocks you'll want to buy.\n1. Apple\nThe burden that inflation is imposing on consumers also poses a threat to some of the biggest, best-run businesses, like Apple (NASDAQ:AAPL), which is currently benefiting from the smartphone upgrade cycle and the rollout of 5G network infrastructure. Any attempt by the Federal Reserve to raise interest rates to contain runaway inflation could cause an economic slowdown by making money more expensive to borrow. Stock valuations would also turn lower.\nThat's not necessarily bad news for investors who might find Apple's $2.8 trillion valuation a bit rich to buy into at the moment. The stock trades at 30 times trailing earnings, or about double its typical multiple. A correction would bring Apple back into the realm of the attainable, even as its business continues jogging forward.\nSales of the iPhone 13 are outpacing those of the iPhone 12 at the same time, but Apple reportedly warned suppliers that demand is waning as the calendar year progresses. It's not necessarily for a lack of consumer desire, but rather the global supply chain constraints that have made it difficult to find the product. Apple previously cut its iPhone production target by 10 million units from its original goal of 90 million.\nAnalysts think many consumers may choose to forgo the iPhone 13 and wait for the next upgrade. Coupled with a market crash, that could put Apple stock at a very attractive entry point with pent-up demand for the next iteration of the iPhone.\n2. Amazon\nFew companies are as essential to the working of the U.S. economy as Amazon (NASDAQ:AMZN). It will account for 41.4% of all online spending in the U.S. this year, according to eMarketer estimates. At the same time, Amazon Web Services (AWS), its cloud infrastructure business, is on track to generate over $60 billion in annual revenue in 2021 based on its year-to-date performance. The company is responsible for thousands of web-based businesses and the federal government's ability to remain online, making Amazon crucial to a well-functioning economy.\nThat won't change if the stock market collapses. Its share of U.S. retail e-commerce sales will be more than 50% larger than the shares of the next nine e-commerce companies combined. Amazon's piece of the online market is nearly six times more than Walmart's second-place share at just 7.2%, and 10 times greater than third-place eBay. E-commerce data tracker Edge by Ascential expects Amazon will see $26.7 billion just in online grocery sales five from now years, or nearly double its current amount.\nAmid rising prices and supply chain woes, Amazon has become a lifeline for many, and that will continue long after any financial restructuring. The stock gained 76% during the first year of the pandemic and took a breather during the reopening of the economy. Amazon shares have been relatively flat all year long. A correction would allow investors to buy a tech stock at a more reasonable valuation even as its crucial role only gets reinforced.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1012,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698444827,"gmtCreate":1640514226693,"gmtModify":1640514226804,"author":{"id":"3580859173247698","authorId":"3580859173247698","name":"ChewWeiKiat","avatar":"https://static.tigerbbs.com/131da1c18d7a77a7044724a63dbc30f8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580859173247698","authorIdStr":"3580859173247698"},"themes":[],"htmlText":"Good good good good yes","listText":"Good good good good yes","text":"Good good good good yes","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698444827","repostId":"2193917872","repostType":4,"repost":{"id":"2193917872","kind":"highlight","pubTimestamp":1640398248,"share":"https://www.laohu8.com/m/news/2193917872?lang=&edition=full","pubTime":"2021-12-25 10:10","market":"us","language":"en","title":"3 Best Buffett Stocks to Buy for the Long Haul","url":"https://stock-news.laohu8.com/highlight/detail?id=2193917872","media":"Motley Fool","summary":"Each of these three big pharma stocks are featured in Berkshire Hathaway's massive portfolio.","content":"<p>Since Warren Buffett took full control of <b>Berkshire Hathaway</b> in 1965, it became a diversified holding company with investments in publicly traded companies totaling nearly $345 billion at the time of writing.</p>\n<p>The Oracle of Omaha's reputation of buying the highest quality businesses means that many individual investors could also benefit from adding these stocks to their portfolios. Here are three healthcare stocks that Buffett owns, which you may also want to consider buying and holding for the long run.</p>\n<h2>1. Johnson & Johnson</h2>\n<p>The first pharma stock within Berkshire's portfolio to contemplate purchasing is <b>Johnson & Johnson</b> (NYSE:JNJ). While the stock is one of Buffett's smallest holdings, valued at just under $55 million, this doesn't take away from its 59 consecutive years of dividend increases that make the stock a Dividend King.</p>\n<p>J&J will be spinning off its slower-growing and less profitable consumer health segment in the next 18 to 24 months, which should allow the company to focus on its faster-growing, more profitable pharmaceutical segment.</p>\n<p>J&J has a strong existing drug portfolio, which should be able to make up for the upcoming 2025 to 2026 patent expirations for its top-selling drug known, Stelara. Year to date, the immunology drug made up just 9.9% of J&J's $69 billion in net sales.</p>\n<p>These drugs include the immunology blockbuster Tremfya, which received its first of three U.S. Food and Drug Administration (FDA) approvals to date in July 2017. Another drug that was recently approved by the FDA was the oncology blockbuster called Darzalex, which received its first of nine FDA approvals to date in November 2015. These two drugs have grown their year-to-date revenue at high-40% clips year over year and should remain under patent most of this decade.</p>\n<p>J&J's enviable existing drug portfolio and its nearly four dozen indications in late-stage clinical trials explain why analysts anticipate that the stock will deliver 8% annual non-GAAP (adjusted) earnings per share (EPS) growth over the next five years.</p>\n<p>Income investors can scoop up J&J's 2.5% dividend yield at a forward P/E ratio of just 16.2 times, which makes the steady healthcare stock a great buy for the long term.</p>\n<h2>2. Bristol Myers Squibb</h2>\n<p>Another Buffett stock that could be a great fit in your portfolio is <b>Bristol Myers Squibb</b> (NYSE:BMY). Berkshire's Bristol Myers Squibb stake totals nearly $1.4 billion, making it one of the largest healthcare holdings in Berkshire's portfolio.</p>\n<p>Bristol Myers Squibb's oncology blockbusters Revlimid and Opdivo and the anticoagulant blockbuster co-owned with <b>Pfizer</b> (NYSE:PFE) named Eliquis each face patent expirations later this decade. While looming patent expirations on three drugs that account for approximately two-thirds of your company's total revenue sounds frightening, this is nothing new; it's just the nature of Bristol Myers Squibb's industry.</p>\n<p>What matters most is that a company is proactive in developing and acquiring its next generation of blockbuster drugs to absorb key patent expirations. With more than 50 compounds in over 40 different disease areas currently in development at Bristol Myers Squibb, this is exactly what the company has been doing for years now.</p>\n<p>As a result, analysts are projecting that Bristol Myers Squibb will be able to generate 6% annual earnings growth through the next five years.</p>\n<p>Yield-hungry investors can buy Bristol Myers Squibb's market-crushing 3.5% yield at a ridiculously cheap forward P/E ratio of 7.9, which is what makes the stock a buy for those looking to hedge against inflation.</p>\n<h2>3. AbbVie</h2>\n<p>Finally, a Buffett stock that'd also be a good fit for income investors is <b>AbbVie</b> (NYSE:ABBV). Berkshire currently holds about $1.9 billion worth of AbbVie stock.</p>\n<p>It's well known at this point that the biopharmaceutical's top-selling drug in the world, Humira, will be facing intense biosimilar competition in the U.S. beginning in 2023. Even though the immunology drug's U.S. sales made up 31% of AbbVie's $41.24 billion total year-to-date sales, the company's pipeline should be able to stabilize and grow its net revenue beyond 2023.</p>\n<p>AbbVie has 54 compounds in various stages of clinical trials, which is why analysts are forecasting that the stock will grow its adjusted EPS 4.5% annually in the next five years.</p>\n<p>AbbVie's massive 4.4% dividend yield can be picked up at a forward P/E ratio of only 9.3. This is an attractive valuation for a stock with the ability to fight off inflation with healthy dividend hikes.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Best Buffett Stocks to Buy for the Long Haul</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Best Buffett Stocks to Buy for the Long Haul\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-25 10:10 GMT+8 <a href=https://www.fool.com/investing/2021/12/24/3-best-buffett-stocks-to-buy-for-the-long-haul/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Since Warren Buffett took full control of Berkshire Hathaway in 1965, it became a diversified holding company with investments in publicly traded companies totaling nearly $345 billion at the time of ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/24/3-best-buffett-stocks-to-buy-for-the-long-haul/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","BMY":"施贵宝","ABBV":"艾伯维公司"},"source_url":"https://www.fool.com/investing/2021/12/24/3-best-buffett-stocks-to-buy-for-the-long-haul/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193917872","content_text":"Since Warren Buffett took full control of Berkshire Hathaway in 1965, it became a diversified holding company with investments in publicly traded companies totaling nearly $345 billion at the time of writing.\nThe Oracle of Omaha's reputation of buying the highest quality businesses means that many individual investors could also benefit from adding these stocks to their portfolios. Here are three healthcare stocks that Buffett owns, which you may also want to consider buying and holding for the long run.\n1. Johnson & Johnson\nThe first pharma stock within Berkshire's portfolio to contemplate purchasing is Johnson & Johnson (NYSE:JNJ). While the stock is one of Buffett's smallest holdings, valued at just under $55 million, this doesn't take away from its 59 consecutive years of dividend increases that make the stock a Dividend King.\nJ&J will be spinning off its slower-growing and less profitable consumer health segment in the next 18 to 24 months, which should allow the company to focus on its faster-growing, more profitable pharmaceutical segment.\nJ&J has a strong existing drug portfolio, which should be able to make up for the upcoming 2025 to 2026 patent expirations for its top-selling drug known, Stelara. Year to date, the immunology drug made up just 9.9% of J&J's $69 billion in net sales.\nThese drugs include the immunology blockbuster Tremfya, which received its first of three U.S. Food and Drug Administration (FDA) approvals to date in July 2017. Another drug that was recently approved by the FDA was the oncology blockbuster called Darzalex, which received its first of nine FDA approvals to date in November 2015. These two drugs have grown their year-to-date revenue at high-40% clips year over year and should remain under patent most of this decade.\nJ&J's enviable existing drug portfolio and its nearly four dozen indications in late-stage clinical trials explain why analysts anticipate that the stock will deliver 8% annual non-GAAP (adjusted) earnings per share (EPS) growth over the next five years.\nIncome investors can scoop up J&J's 2.5% dividend yield at a forward P/E ratio of just 16.2 times, which makes the steady healthcare stock a great buy for the long term.\n2. Bristol Myers Squibb\nAnother Buffett stock that could be a great fit in your portfolio is Bristol Myers Squibb (NYSE:BMY). Berkshire's Bristol Myers Squibb stake totals nearly $1.4 billion, making it one of the largest healthcare holdings in Berkshire's portfolio.\nBristol Myers Squibb's oncology blockbusters Revlimid and Opdivo and the anticoagulant blockbuster co-owned with Pfizer (NYSE:PFE) named Eliquis each face patent expirations later this decade. While looming patent expirations on three drugs that account for approximately two-thirds of your company's total revenue sounds frightening, this is nothing new; it's just the nature of Bristol Myers Squibb's industry.\nWhat matters most is that a company is proactive in developing and acquiring its next generation of blockbuster drugs to absorb key patent expirations. With more than 50 compounds in over 40 different disease areas currently in development at Bristol Myers Squibb, this is exactly what the company has been doing for years now.\nAs a result, analysts are projecting that Bristol Myers Squibb will be able to generate 6% annual earnings growth through the next five years.\nYield-hungry investors can buy Bristol Myers Squibb's market-crushing 3.5% yield at a ridiculously cheap forward P/E ratio of 7.9, which is what makes the stock a buy for those looking to hedge against inflation.\n3. AbbVie\nFinally, a Buffett stock that'd also be a good fit for income investors is AbbVie (NYSE:ABBV). Berkshire currently holds about $1.9 billion worth of AbbVie stock.\nIt's well known at this point that the biopharmaceutical's top-selling drug in the world, Humira, will be facing intense biosimilar competition in the U.S. beginning in 2023. Even though the immunology drug's U.S. sales made up 31% of AbbVie's $41.24 billion total year-to-date sales, the company's pipeline should be able to stabilize and grow its net revenue beyond 2023.\nAbbVie has 54 compounds in various stages of clinical trials, which is why analysts are forecasting that the stock will grow its adjusted EPS 4.5% annually in the next five years.\nAbbVie's massive 4.4% dividend yield can be picked up at a forward P/E ratio of only 9.3. This is an attractive valuation for a stock with the ability to fight off inflation with healthy dividend hikes.","news_type":1},"isVote":1,"tweetType":1,"viewCount":822,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691605784,"gmtCreate":1640178479190,"gmtModify":1640178479287,"author":{"id":"3580859173247698","authorId":"3580859173247698","name":"ChewWeiKiat","avatar":"https://static.tigerbbs.com/131da1c18d7a77a7044724a63dbc30f8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580859173247698","authorIdStr":"3580859173247698"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691605784","repostId":"1123940793","repostType":4,"repost":{"id":"1123940793","kind":"news","pubTimestamp":1640153635,"share":"https://www.laohu8.com/m/news/1123940793?lang=&edition=full","pubTime":"2021-12-22 14:13","market":"us","language":"en","title":"Is Rivian Stock A Buy, Sell, Or Hold?","url":"https://stock-news.laohu8.com/highlight/detail?id=1123940793","media":"Seeking Alpha","summary":"Summary\n\nRivian stock has dropped more than 25% since our last Neutral call.\nThe company reported a ","content":"<p><b>Summary</b></p>\n<ul>\n <li>Rivian stock has dropped more than 25% since our last Neutral call.</li>\n <li>The company reported a slight production target miss in its FQ3 earnings call. However, we don't think investors should be overly worried.</li>\n <li>We discuss why we think RIVN stock is a Buy now.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/69bdd77748b1c27c695aff2846bb30c6\" tg-width=\"1536\" tg-height=\"1024\" referrerpolicy=\"no-referrer\"><span>Michael M. Santiago/Getty Images News</span></p>\n<p><b>Investment Thesis</b></p>\n<p>Rivian Automotive, Inc. (RIVN) recently released its first earnings reports for FQ3'21 as a public company. Notably, the company missed its 1,200 vehicle production target by \"a few hundred vehicles.\" However, we weren't surprised, given the current supply chain bottlenecks and the challenges in ramping production. Moreover, we don't think investors should be unduly concerned about its short-term production goal. Management was clear as it emphasized that its long-term production targets remain unaffected.</p>\n<p>Nevertheless, we believe that ramping production successfully will continue to be a key hurdle facing CEO RJ Scaringe & Co. Investors sent the stock tumbling after its earnings report, which we believe the market took the opportunity to pare down risk. After all, RIVN stock had traded at an incredible market cap of $112.8B when we wrote our previous article. Following the recent sell-off, Rivian's market cap has dropped to $88B. Therefore, we believe it's an appropriate time to revisit our thesis on RIVN stock post-FQ3 earnings.</p>\n<p>We also discuss why we think the stock seems fairly valued now.</p>\n<p><b>Rivian Market Cap Trend</b></p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a528b02874c529215e0428c40adc5ad1\" tg-width=\"640\" tg-height=\"331\" referrerpolicy=\"no-referrer\"><span>RIVN market cap analysis (as of 17 December'21).</span></p>\n<p>Readers can quickly glean that Rivian's market cap has dropped dramatically back to where it started life as a public company. It last registered a market cap of $88B, while it began trading with a market cap of $83.6B in early November.</p>\n<p>Nevertheless, Rivian's market cap still exceeded Ford (F) and General Motors (GM) market cap even as it just started making deliveries in September. Some investors find it incredulous that a company that hasn't even ramped production could be worth more than both the US auto leaders.</p>\n<p><b>Why We Think Rivian Investors Remain Optimistic Post-FQ3</b></p>\n<p>Rivian's report card wasn't a disaster, even if the company missed its production guidance for 2021. CEO RJ Scaringe offered assurances as he emphasized (edited):</p>\n<blockquote>\n For 2021, \n <i>we expect to produce a few hundred vehicles short of our initial 1,200 vehicle production target</i>. We do not believe any of our supply chain challenges represent long-term systemic issues. We remain well-positioned to capture and drive the accelerated large-scale adoption of sustainable transportation. However, a small number of suppliers or small number of components may be ramping a little slower, creating constraints or bottlenecks. Those challenges have been really a focal point for us over the last two and a half, three months. \n <i>But, these issues are short-term in nature and they are solvable problems</i>. So, we don't see any long-term systemic challenges associated with ramping the supply chain. (Rivian's FQ3'21 earnings call)\n</blockquote>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/36ec61d947f0a1da5f4d5883a8941a7d\" tg-width=\"640\" tg-height=\"396\" referrerpolicy=\"no-referrer\"><span>Rivian planned production capacity and delivery consensus estimates. Data source: S&P Capital IQ, Barron's</span></p>\n<p>Rivian telegraphed that it would be commencing its new Georgia production facility in mid'22 and ready to begin production from 2024. Georgia's planned annual run rate is estimated at 400K. Therefore, it would afford Rivian a collective annual production capacity of 600K if we include its Illinois facility. Nevertheless, the company did not specify how long it would take to ramp production to its planned capacity. However, consensus estimates point to a relatively positive ramp through FY25. As a result, Rivian is estimated to deliver about 40K of vehicles in FY22. However, it would reach the 360K milestone by FY25, registering an estimated delivery CAGR of 108%. Its 360K estimate includes the 100K EDV orders from its exclusive last-mile delivery partner and cornerstone investor Amazon (AMZN).</p>\n<p>There's little doubt that the delivery cadence estimates look very aggressive. But, if done well, it's also not impossible. Keen investors should recall that Tesla (TSLA) took just two years to ramp Giga Shanghai from zero to its current 600K annual run rate. It has even recently made new investments to enhance its production capacity further. Rivian also seems highly confident that they can ramp successfully, as CEO RJ Scaringe emphasized (edited):</p>\n<blockquote>\n We've architected the product development to be capable of running more than one program and launching more than one program at once, but also to have those fast feedback loops between the different programs. So with that, the commercial van has actually learned a lot from the R1 platform and the R1 platform launch. What you see in terms of the facility in Georgia, is key for us from an expansion point of view. We're quite confident in the path ahead. All three of our vehicles have been certified for sale and they're being produced on two different production lines. \n <i>The organization was architected to facilitate running and operating multiple programs at the same time</i>. And so as we now look at what the ramp will look like for both R1T and R1S into next year, it really positions us to rapidly grow through the course of 2022. (Rivian's FQ3'21 earnings call)\n</blockquote>\n<p>While it's still early, Rivian investors are undoubtedly confident that the company can deliver on its production cadence to meet its delivery milestones. The company is not facing a demand issue compared to short-term supply constraints. They updated that R1 orders have climbed to 71K from 55K in the previous update. Nevertheless, these are cancelable orders, as their delivery timeline has been stretched to 2023 if a new order is placed now. Given that auto leaders General Motors, Ford, and Tesla will also be expected to compete with their pickup trucks soon, Rivian must maintain its production cadence. Therefore, we encourage investors to monitor their production milestones very carefully moving ahead.</p>\n<p><b>Investors Must Carefully Monitor Amazon's EDV Range</b></p>\n<p>The partnership with Amazon is critical to jumpstarting Rivian's ambitions into the commercial fleet segment. Not only does it offer the opportunity of massive fleet sales, but it also sells its fleet management subscriptions as part of its commercial sales. Consequently, it introduces a recurring software revenue stream component on top of its hardware revenue. It also applies to the Amazon fleet, as Rivian accentuated: \"That software subscription goes live basically now on the commercial side.\"</p>\n<p>Rivian is expected to deliver 10K EDV by 2022 following \"months of testing in 15 cities.\" Investors should remember that Amazon retains the right to change its number of orders. Therefore it's critical that Rivian can meet Amazon's expectations. We believe it has also driven Rivian to ramp production quickly. Given how quickly they secured their second production facility, we believe that the company seems confident in meeting its production targets, and consequently, Amazon's orders.</p>\n<p>Rivian emphasized that its EDV is capable of 201 miles range, and it is on track to deliver its vehicles to Amazon. However, a previous report by The Information highlighted some challenges in Amazon's testing, on top of its battery draining problem. The Information reported (edited):</p>\n<blockquote>\n Rivian said the Amazon vans would have a range of between 120 miles and 150 miles depending on their size. But one driver involved in testing the vans said the range could be much less, depending on the weather. The driver who spoke to The Information said the battery drained about 40% faster than normal if the van’s heating or cooling was on. As a result, drivers have been testing the vans on what they dubbed “nursery routes,” where vans didn’t venture too far away from the contractors’ headquarters. (The Information)\n</blockquote>\n<p>Nevertheless, Amazon's director of Global Fleets and Products, Ross Rachey, noted that once the vans are in production, \"they would have a range of 150 miles, which is double the range of the majority of Amazon's routes.\" Notably, the company also quickly emphasized that these test vans are not fully developed yet.</p>\n<p>We believe a successful launch program with Amazon could open up many potential opportunities outside of the Last Mile segment. Investors should note that Amazon's exclusive partnership with Rivian is limited to Last Mile. But, the commercial space is much larger than the Last Mile segment. Rivian also raved about its market opportunities in the larger commercial space, as Scaringe added (edited):</p>\n<blockquote>\n <i>Amazon represents such a large pool of demand for us.</i>So it's really critical that we do not starve them of vehicles. Nevertheless, the RCV platform was architected and designed \n <i>fully contemplating vehicles beyond Last Mile, such as in the cargo space</i>, or in the workspace. So there's a whole host of opportunities that exists both in large volumes, but also across a very long spread-out tail of commercial applications. Thus, we also have an eye on launching non-EDV versions on the RCV platform to capitalize on these opportunities. (Rivian's FQ3'21 earnings call)\n</blockquote>\n<p><b>So, is RIVN Stock a Buy/Hold/Sell Now?</b></p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/264dc3dc91fc844d920e73a7f69cf920\" tg-width=\"640\" tg-height=\"395\" referrerpolicy=\"no-referrer\"><span>Rivian revenue and adjusted EBIT margins mean consensus estimates. Data source: S&P Capital IQ</span></p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1069e7fc16920da396615f6df6ff5951\" tg-width=\"640\" tg-height=\"396\" referrerpolicy=\"no-referrer\"><span>RIVN and TSLA stock EV/Fwd Revenue valuation comps. Data source: S&P Capital IQ</span></p>\n<p>Consensus estimates point to a largely successful ramp, as we explained earlier. As a result, Rivian's revenue is estimated to reach $27.84B by FY25. However, the company is not expected to be profitable based on adjusted EBIT margins by then. Therefore, investors are encouraged to monitor its production ramp and profitability dynamics moving forward carefully.</p>\n<p>Nevertheless, its valuations have dropped significantly since its earlier momentum spike. The stock has declined more than 25% since our Neutral call, as we encouraged investors to wait for the dip.</p>\n<p>If we consider Rivian's valuations against Tesla moving forward, it may seem more reasonable than the EV leader. However, investors should note that Tesla is already a solidly profitable EV maker. It also has proven its production ramp capabilities exceptionally well. Moreover, its brand value has also increased tremendously globally. Therefore, comparing their revenue multiples directly without adjusting for Tesla's advantages would not make sense.</p>\n<p>Based on Rivian stock's EV/FY25 revenue multiple of 3.4x, it's trading at 50% of Tesla's FY25 revenue multiple. Therefore, we think RIVN stock looks fairly valued now. Nevertheless, we believe that RIVN stock remains a highly speculative play. However, the company seems to be getting well on track to meet its mid-term production guidance. Therefore, the current weakness could offer speculative investors a potential opportunity to add exposure at a more reasonable valuation.</p>\n<p>Consequently,<i>we revise our rating on RIVN stock to Buy.</i>However, we would like to caution that RIVN stock may be suitable for speculative investors only. Moreover, the stock could continue to exhibit tremendous volatility. Therefore, investors are encouraged to add in phases.</p>\n<p>This article was written by JR Research.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is Rivian Stock A Buy, Sell, Or Hold?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Rivian Stock A Buy, Sell, Or Hold?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-22 14:13 GMT+8 <a href=https://seekingalpha.com/article/4476199-rivian-stock-buy-sell-hold><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nRivian stock has dropped more than 25% since our last Neutral call.\nThe company reported a slight production target miss in its FQ3 earnings call. However, we don't think investors should be ...</p>\n\n<a href=\"https://seekingalpha.com/article/4476199-rivian-stock-buy-sell-hold\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"RIVN":"Rivian Automotive, Inc."},"source_url":"https://seekingalpha.com/article/4476199-rivian-stock-buy-sell-hold","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1123940793","content_text":"Summary\n\nRivian stock has dropped more than 25% since our last Neutral call.\nThe company reported a slight production target miss in its FQ3 earnings call. However, we don't think investors should be overly worried.\nWe discuss why we think RIVN stock is a Buy now.\n\nMichael M. Santiago/Getty Images News\nInvestment Thesis\nRivian Automotive, Inc. (RIVN) recently released its first earnings reports for FQ3'21 as a public company. Notably, the company missed its 1,200 vehicle production target by \"a few hundred vehicles.\" However, we weren't surprised, given the current supply chain bottlenecks and the challenges in ramping production. Moreover, we don't think investors should be unduly concerned about its short-term production goal. Management was clear as it emphasized that its long-term production targets remain unaffected.\nNevertheless, we believe that ramping production successfully will continue to be a key hurdle facing CEO RJ Scaringe & Co. Investors sent the stock tumbling after its earnings report, which we believe the market took the opportunity to pare down risk. After all, RIVN stock had traded at an incredible market cap of $112.8B when we wrote our previous article. Following the recent sell-off, Rivian's market cap has dropped to $88B. Therefore, we believe it's an appropriate time to revisit our thesis on RIVN stock post-FQ3 earnings.\nWe also discuss why we think the stock seems fairly valued now.\nRivian Market Cap Trend\nRIVN market cap analysis (as of 17 December'21).\nReaders can quickly glean that Rivian's market cap has dropped dramatically back to where it started life as a public company. It last registered a market cap of $88B, while it began trading with a market cap of $83.6B in early November.\nNevertheless, Rivian's market cap still exceeded Ford (F) and General Motors (GM) market cap even as it just started making deliveries in September. Some investors find it incredulous that a company that hasn't even ramped production could be worth more than both the US auto leaders.\nWhy We Think Rivian Investors Remain Optimistic Post-FQ3\nRivian's report card wasn't a disaster, even if the company missed its production guidance for 2021. CEO RJ Scaringe offered assurances as he emphasized (edited):\n\n For 2021, \n we expect to produce a few hundred vehicles short of our initial 1,200 vehicle production target. We do not believe any of our supply chain challenges represent long-term systemic issues. We remain well-positioned to capture and drive the accelerated large-scale adoption of sustainable transportation. However, a small number of suppliers or small number of components may be ramping a little slower, creating constraints or bottlenecks. Those challenges have been really a focal point for us over the last two and a half, three months. \n But, these issues are short-term in nature and they are solvable problems. So, we don't see any long-term systemic challenges associated with ramping the supply chain. (Rivian's FQ3'21 earnings call)\n\nRivian planned production capacity and delivery consensus estimates. Data source: S&P Capital IQ, Barron's\nRivian telegraphed that it would be commencing its new Georgia production facility in mid'22 and ready to begin production from 2024. Georgia's planned annual run rate is estimated at 400K. Therefore, it would afford Rivian a collective annual production capacity of 600K if we include its Illinois facility. Nevertheless, the company did not specify how long it would take to ramp production to its planned capacity. However, consensus estimates point to a relatively positive ramp through FY25. As a result, Rivian is estimated to deliver about 40K of vehicles in FY22. However, it would reach the 360K milestone by FY25, registering an estimated delivery CAGR of 108%. Its 360K estimate includes the 100K EDV orders from its exclusive last-mile delivery partner and cornerstone investor Amazon (AMZN).\nThere's little doubt that the delivery cadence estimates look very aggressive. But, if done well, it's also not impossible. Keen investors should recall that Tesla (TSLA) took just two years to ramp Giga Shanghai from zero to its current 600K annual run rate. It has even recently made new investments to enhance its production capacity further. Rivian also seems highly confident that they can ramp successfully, as CEO RJ Scaringe emphasized (edited):\n\n We've architected the product development to be capable of running more than one program and launching more than one program at once, but also to have those fast feedback loops between the different programs. So with that, the commercial van has actually learned a lot from the R1 platform and the R1 platform launch. What you see in terms of the facility in Georgia, is key for us from an expansion point of view. We're quite confident in the path ahead. All three of our vehicles have been certified for sale and they're being produced on two different production lines. \n The organization was architected to facilitate running and operating multiple programs at the same time. And so as we now look at what the ramp will look like for both R1T and R1S into next year, it really positions us to rapidly grow through the course of 2022. (Rivian's FQ3'21 earnings call)\n\nWhile it's still early, Rivian investors are undoubtedly confident that the company can deliver on its production cadence to meet its delivery milestones. The company is not facing a demand issue compared to short-term supply constraints. They updated that R1 orders have climbed to 71K from 55K in the previous update. Nevertheless, these are cancelable orders, as their delivery timeline has been stretched to 2023 if a new order is placed now. Given that auto leaders General Motors, Ford, and Tesla will also be expected to compete with their pickup trucks soon, Rivian must maintain its production cadence. Therefore, we encourage investors to monitor their production milestones very carefully moving ahead.\nInvestors Must Carefully Monitor Amazon's EDV Range\nThe partnership with Amazon is critical to jumpstarting Rivian's ambitions into the commercial fleet segment. Not only does it offer the opportunity of massive fleet sales, but it also sells its fleet management subscriptions as part of its commercial sales. Consequently, it introduces a recurring software revenue stream component on top of its hardware revenue. It also applies to the Amazon fleet, as Rivian accentuated: \"That software subscription goes live basically now on the commercial side.\"\nRivian is expected to deliver 10K EDV by 2022 following \"months of testing in 15 cities.\" Investors should remember that Amazon retains the right to change its number of orders. Therefore it's critical that Rivian can meet Amazon's expectations. We believe it has also driven Rivian to ramp production quickly. Given how quickly they secured their second production facility, we believe that the company seems confident in meeting its production targets, and consequently, Amazon's orders.\nRivian emphasized that its EDV is capable of 201 miles range, and it is on track to deliver its vehicles to Amazon. However, a previous report by The Information highlighted some challenges in Amazon's testing, on top of its battery draining problem. The Information reported (edited):\n\n Rivian said the Amazon vans would have a range of between 120 miles and 150 miles depending on their size. But one driver involved in testing the vans said the range could be much less, depending on the weather. The driver who spoke to The Information said the battery drained about 40% faster than normal if the van’s heating or cooling was on. As a result, drivers have been testing the vans on what they dubbed “nursery routes,” where vans didn’t venture too far away from the contractors’ headquarters. (The Information)\n\nNevertheless, Amazon's director of Global Fleets and Products, Ross Rachey, noted that once the vans are in production, \"they would have a range of 150 miles, which is double the range of the majority of Amazon's routes.\" Notably, the company also quickly emphasized that these test vans are not fully developed yet.\nWe believe a successful launch program with Amazon could open up many potential opportunities outside of the Last Mile segment. Investors should note that Amazon's exclusive partnership with Rivian is limited to Last Mile. But, the commercial space is much larger than the Last Mile segment. Rivian also raved about its market opportunities in the larger commercial space, as Scaringe added (edited):\n\nAmazon represents such a large pool of demand for us.So it's really critical that we do not starve them of vehicles. Nevertheless, the RCV platform was architected and designed \n fully contemplating vehicles beyond Last Mile, such as in the cargo space, or in the workspace. So there's a whole host of opportunities that exists both in large volumes, but also across a very long spread-out tail of commercial applications. Thus, we also have an eye on launching non-EDV versions on the RCV platform to capitalize on these opportunities. (Rivian's FQ3'21 earnings call)\n\nSo, is RIVN Stock a Buy/Hold/Sell Now?\nRivian revenue and adjusted EBIT margins mean consensus estimates. Data source: S&P Capital IQ\nRIVN and TSLA stock EV/Fwd Revenue valuation comps. Data source: S&P Capital IQ\nConsensus estimates point to a largely successful ramp, as we explained earlier. As a result, Rivian's revenue is estimated to reach $27.84B by FY25. However, the company is not expected to be profitable based on adjusted EBIT margins by then. Therefore, investors are encouraged to monitor its production ramp and profitability dynamics moving forward carefully.\nNevertheless, its valuations have dropped significantly since its earlier momentum spike. The stock has declined more than 25% since our Neutral call, as we encouraged investors to wait for the dip.\nIf we consider Rivian's valuations against Tesla moving forward, it may seem more reasonable than the EV leader. However, investors should note that Tesla is already a solidly profitable EV maker. It also has proven its production ramp capabilities exceptionally well. Moreover, its brand value has also increased tremendously globally. Therefore, comparing their revenue multiples directly without adjusting for Tesla's advantages would not make sense.\nBased on Rivian stock's EV/FY25 revenue multiple of 3.4x, it's trading at 50% of Tesla's FY25 revenue multiple. Therefore, we think RIVN stock looks fairly valued now. Nevertheless, we believe that RIVN stock remains a highly speculative play. However, the company seems to be getting well on track to meet its mid-term production guidance. Therefore, the current weakness could offer speculative investors a potential opportunity to add exposure at a more reasonable valuation.\nConsequently,we revise our rating on RIVN stock to Buy.However, we would like to caution that RIVN stock may be suitable for speculative investors only. Moreover, the stock could continue to exhibit tremendous volatility. Therefore, investors are encouraged to add in phases.\nThis article was written by JR Research.","news_type":1},"isVote":1,"tweetType":1,"viewCount":745,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}
